Routine Diagnostic Test for Lemierre Syndrome Is Required
|
By LabMedica International staff writers Posted on 09 Dec 2009 |
Physicians when diagnosing sore throat, or pharyngitis, in adolescents and young adults must consider the newly identified, potentially dangerous Fusobacterium necrophorum as the source of infection. The bacterium can cause Lemierre syndrome, a potentially dangerous condition.
Symptoms of Lemierre syndrome include unilateral neck swelling, rigors, night sweats, or high fevers. Currently there is no routine test for F. necrophorum pharyngitis, and a CT scan is required to detect Lemierre syndrome. In the event that the disease is diagnosed, aggressive treatment with antibiotics such as a combination of penicillin and metronidazole or with clindamycin alone is appropriate.
Lemierre syndrome mostly affects adolescents and young adults and rarely is seen in preadolescents. It begins with a sore throat, followed by an infected jugular vein after four to five days. Abscesses in other parts of the body may occur. Approximately 5 percent of people who get Lemierre syndrome die.
Physicians are trained to suspect group A streptococcal bacteria as the primary cause of pharyngitis. But according to findings by investigators at the University of Alabama at Birmingham (UAB; USA), and published on December 1, 2009 in the Annals of Internal Medicine, sore throat in young adults and adolescents that worsens or is strep-negative, could be due to F. necrophorum. Although group A strep. is associated with rheumatic fever, the incidence and rate of Lemierre syndrome following exposure to F. necrophorum is much higher and associated with greater morbidity and mortality.
Robert Centor, M.D., professor of internal medicine, associate dean of medicine at UAB and the paper's lead author, said, "F. necrophorum, which only has been recognized as a potential cause of pharyngitis in adolescents and young adults in the past five years, may cause up to 10 percent of sore throat in those 15-24 years of age. More important, F. necrophorum is associated with a rare but life-threatening complication called Lemierre syndrome."
Prof. Centor added that he hopes this analysis will lead to better diagnostic tests for the presence of F. necrophorum.
Related Links:
University of Alabama at Birmingham
Symptoms of Lemierre syndrome include unilateral neck swelling, rigors, night sweats, or high fevers. Currently there is no routine test for F. necrophorum pharyngitis, and a CT scan is required to detect Lemierre syndrome. In the event that the disease is diagnosed, aggressive treatment with antibiotics such as a combination of penicillin and metronidazole or with clindamycin alone is appropriate.
Lemierre syndrome mostly affects adolescents and young adults and rarely is seen in preadolescents. It begins with a sore throat, followed by an infected jugular vein after four to five days. Abscesses in other parts of the body may occur. Approximately 5 percent of people who get Lemierre syndrome die.
Physicians are trained to suspect group A streptococcal bacteria as the primary cause of pharyngitis. But according to findings by investigators at the University of Alabama at Birmingham (UAB; USA), and published on December 1, 2009 in the Annals of Internal Medicine, sore throat in young adults and adolescents that worsens or is strep-negative, could be due to F. necrophorum. Although group A strep. is associated with rheumatic fever, the incidence and rate of Lemierre syndrome following exposure to F. necrophorum is much higher and associated with greater morbidity and mortality.
Robert Centor, M.D., professor of internal medicine, associate dean of medicine at UAB and the paper's lead author, said, "F. necrophorum, which only has been recognized as a potential cause of pharyngitis in adolescents and young adults in the past five years, may cause up to 10 percent of sore throat in those 15-24 years of age. More important, F. necrophorum is associated with a rare but life-threatening complication called Lemierre syndrome."
Prof. Centor added that he hopes this analysis will lead to better diagnostic tests for the presence of F. necrophorum.
Related Links:
University of Alabama at Birmingham
Latest Microbiology News
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
- Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
- Study Finds Hidden Mpox Infections May Drive Ongoing Spread
- Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
- Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
- Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
- Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria
- Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
- Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
- Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections
- Antibiotic Resistance Genes Found in Newborns Within Hours of Birth
- Rapid Color Test Stratifies Virulent and Resistant Staph Strains
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








